An Early Phase 1 interventional study of [F-18]BCPP-EF in Cocaine Use Disorder and Healthy Controls Group - Age and Sex-matched, sponsored by Rajesh Narendran. Recruiting at 1 site in United States. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-14.
Sponsored by Rajesh Narendran · Early Phase 1, Interventional, and Basic science
Studies proposed in this application will image mitochondrial Complex-I in cocaine use disorder (CUD) and matched healthy controls
This study uses [18F]BCPP-EF positron emission tomography (PET) to image mitochondrial complex-I in subjects with cocaine use disorder (CUD) and healthy controls (HC). Correlating PET outcome measures with relapse to cocaine in this study will clarify the mechanisms by which abnormal brain energetics modulate addictive behaviors.
This study is supported by "the NIH The Helping to End Addiction Long-term® Initiative, HEAL Initiative (https://www.nih.gov/heal)"
Cocaine use disorders (CUD)
Healthy controls (HC)
\[F-18\]BCPP-EF
Drug: [F-18]BCPP-EF
Radiotracer
Orbitofrontal Cortex [F-18]BCPP-EF VT
VT is the volume of distribution expressed relative to total plasma radioligand concentration
Time frame: Baseline scan (time 0)
Midbrain [F-18]BCPP-EF VT
VT is the volume of distribution expressed relative to total plasma radioligand concentration
Time frame: Baseline scan (time 0)
Ventral Striatum [F-18]BCPP-EF VT
VT is the volume of distribution expressed relative to total plasma radioligand concentration
Time frame: Baseline scan (time 0)
Plan to share: Yes — All individual participant data that underlie the results reported in the publication or upon study completion will be shared after de-identification via the Open Neuro PET
Supporting information: Study protocol
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rajesh Narendran